Canbex Therapeutics' Series A Round

Canbex Therapeutics raised a round of funding on April 08, 2013.

Canbex Therapeutics is dedicated to treating spasticity in multiple sclerosis (MS) and potentially other disorders. Spasticity is a debilitating and painful symptom of MS that consists of involuntary …

Articles about Canbex Therapeutics' Series A Round: